Fayda Merdan, Aksu Gorkem, Yaman Agaoglu Fulya, Karadeniz Ahmet, Darendeliler Emin, Altun Musa, Hafiz Gunter
Kocaeli University, Faculty of Medicine, Department of Radiation Oncology, Turkey.
J Craniomaxillofac Surg. 2009 Jan;37(1):42-8. doi: 10.1016/j.jcms.2008.07.007. Epub 2008 Sep 18.
Thirty adult patients with head and neck soft tissue sarcoma (HNSTS) treated between 1987 and 2000 were retrospectively analysed.
The most frequent histopathological subtypes were chondrosarcomas (27%) and malignant fibrous histiocytoma (20%). The surgical resection was performed in 25 of the 30 patients (83%). Twenty-three patients in the surgical resection arm received postoperative radiotherapy.
Five-year local control rates for patients with negative surgical margins (n=9), microscopically positive disease (n=10), gross residual disease (n=6) and inoperable cases (n=5) were 64, 70, 20 and 0%, respectively. However, there was no significant difference in local control between patients with negative or microscopically positive disease who received postoperative radiotherapy (71 vs. 70%). The patients who received doses>or=60 Gy had significantly higher local control rates than the ones who received doses lower than 60 Gy (p=0.048). The local control rates were lower in patients with grade 2-3 tumours when compared with grade 1 tumours (44 vs. 83%). The median overall survival of whole group was 31 months. Median survivals of patients receiving both surgery and radiotherapy with negative and microscopically positive margins were significantly better than patients who were not treated with surgery (34.8 and 36 vs. 13.3 months).
Our results confirm that the optimal treatment of HNSTSs is complete surgical excision, and that postoperative adjuvant radiotherapy clearly improves local control.
对1987年至2000年间接受治疗的30例成年头颈部软组织肉瘤(HNSTS)患者进行回顾性分析。
最常见的组织病理学亚型为软骨肉瘤(27%)和恶性纤维组织细胞瘤(20%)。30例患者中有25例(83%)接受了手术切除。手术切除组的23例患者接受了术后放疗。
手术切缘阴性(n = 9)、显微镜下阳性病变(n = 10)、肉眼残留病变(n = 6)和无法手术的病例(n = 5)患者的5年局部控制率分别为64%、70%、20%和0%。然而,接受术后放疗的手术切缘阴性或显微镜下阳性病变患者的局部控制率无显著差异(71%对70%)。接受剂量≥60 Gy的患者局部控制率显著高于接受剂量低于60 Gy的患者(p = 0.048)。与1级肿瘤患者相比,2 - 3级肿瘤患者的局部控制率较低(44%对83%)。全组的中位总生存期为31个月。手术切缘阴性和显微镜下阳性且接受手术和放疗的患者的中位生存期明显优于未接受手术治疗的患者(34.8个月和36个月对13.3个月)。
我们的结果证实,HNSTS的最佳治疗方法是完整的手术切除,术后辅助放疗明显提高局部控制率。